Brown (1994) suggests that identibed placebo should be used as a treatment since many placebo-controlled trials show much improvement during placebo treat ment. Among those improved during placebo treat ment, we must distinguish those improved from the treatment from those who spontaneously remit. Studies of placebo response indicate that the most consistent robust predictor is episode duration. This argues against a specibc placebo effect. Rather, benefIt during placebo treatment is strongly related to the probability of spon taneous remission.
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Brown argues that placebo treatment provides greater symptom relief than waiting list controls, but unfortunately waiting list controls are not "no treat ment." For instance, Brown states that psychotherapy is more effective than waiting list controls but not more effective than pill placebo controls, whereas pill placebo is more effective than waiting lists. Anything worse than pill placebo is probably toxic.
Borgatta (1959) One wrinkle here would be the need for an esti mate of the patient's belief whether they are actually getting placebo or not, as well as their view of the credi bility of such treatment. Further, since it is likely that many patients would not accept going into a trial of identifIed placebo, the trial might be invalidated by a large differential refusal rate. This could, in part, be han dled by the techniques developed by Rosenbaum and Rubin (1983) and Lavori and Keller (1988) 
